Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria.

Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria.

<h4>Objective</h4>There is a need for reliable serological assays to determine accurate estimates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence. Most single target antigen assays have shown some limitations in Africa. To assess the performance of a multi-...

Full description

Bibliographic Details
Main Authors: Nnaemeka C Iriemenam, Fehintola A Ige, Stacie M Greby, Augustine Mpamugo, Ado G Abubakar, Ayuba B Dawurung, Mudiaga K Esiekpe, Andrew N Thomas, Mary U Okoli, Samuel S Awala, Blessing N Ugboaja, Chicago C Achugbu, Ifeanyichukwu Odoh, Felicia D Nwatu, Temitope Olaleye, Loveth Akayi, Oluwaseun O Akinmulero, Joseph Dattijo, Edewede Onokevbagbe, Olumide Okunoye, Nwando Mba, Ndidi P Agala, Mabel Uwandu, Maureen Aniedobe, Kristen A Stafford, Alash'le Abimiku, Yohhei Hamada, Mahesh Swaminathan, McPaul I Okoye, Laura C Steinhardt, Rosemary Audu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0266184

Internet

https://doi.org/10.1371/journal.pone.0266184

Similar Items